These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3141846)

  • 1. Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo.
    Mizuno Y; Suzuki K; Sone N; Saitoh T
    Neurosci Lett; 1988 Sep; 91(3):349-53. PubMed ID: 3141846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y; Sone N; Saitoh T
    J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
    Suzuki K; Mizuno Y; Yoshida M
    Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
    Cheeseman AJ; Clark JB
    J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I; Heikkila RE; Nicklas WJ
    J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
    Nicklas WJ; Vyas I; Heikkila RE
    Life Sci; 1985 Jul; 36(26):2503-8. PubMed ID: 2861548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.
    Suzuki K; Mizuno Y; Yoshida M
    Neurochem Res; 1990 Jul; 15(7):705-10. PubMed ID: 1975653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo.
    Mizuno Y; Suzuki K; Sone N
    Adv Neurol; 1990; 53():197-200. PubMed ID: 2122644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain.
    Mizuno Y; Sone N; Suzuki K; Saitoh T
    J Neurol Sci; 1988 Aug; 86(1):97-110. PubMed ID: 3262717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
    Mizuno Y
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline.
    Suzuki K; Mizuno Y; Yoshida M
    Neurosci Lett; 1988 Mar; 86(1):105-8. PubMed ID: 3129681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.
    Mizuno Y; Saitoh T; Sone N
    Biochem Biophys Res Commun; 1987 Feb; 143(1):294-9. PubMed ID: 3103619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
    Johannessen JN; Chiueh CC; Bacon JP; Garrick NA; Burns RS; Weise VK; Kopin IJ; Parisi JE; Markey SP
    J Neurochem; 1989 Aug; 53(2):582-9. PubMed ID: 2568405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
    Youngster SK; Nicklas WJ; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
    Lydén-Sokolowski A; Larsson BS; Lindquist NG
    Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
    Kass GE; Wright JM; Nicotera P; Orrenius S
    Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
    Lee EH
    Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase.
    Ramsay RR; Kowal AT; Johnson MK; Salach JI; Singer TP
    Arch Biochem Biophys; 1987 Dec; 259(2):645-9. PubMed ID: 2827583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.